Bamlanivimab was produced by Ely Lilly and purchased by the federal government for distribution across the country. It shows promise in helping reduce hospitalizations of high-risk patients who have contracted the virus.
CHI Health has received a limited supply of Bamlanivimab to be administered at multiple sites across Nebraska, Western Iowa, and Bismarck, ND. It will only be given as an intravenous infusion at a dedicated infusion clinic only. You must have a referral and order from a provider in order to receive this medication.
Requirements for administration:
- Must be 12 years or older.
- Must have a confirmed positive SARS-CoV-2 (COVID-19) virus test AND be at High Risk for Hospitalization.
- Must have a physician referral.